Regeneron Pharmaceuticals, a global biotech company founded in New York City, is more than doubling its manufacturing ...
Regeneron Pharmaceuticals is proposing to spend $2 billion to open a manufacturing facility in Saratoga Springs.The company ...
Quad/Graphics (QUAD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Regeneron is building a $2 billion production facility in Saratoga Springs that will allow the Tarrytown drugmaker to double ...
SUSSEX, Wis. (AP) — SUSSEX, Wis. (AP) — Quad/Graphics Inc. (QUAD) on Tuesday reported net income of $10.2 million in its third quarter. On a per-share basis, the Sussex, Wisconsin-based company said ...
Quad/Graphics (QUAD) is scheduled to announce Q3 earnings results on Tuesday, October 28th, after market close.The consensus EPS Estimate is $0.27 (+3.8% Y/Y) and the consensus Revenue Estimate is ...
Quad/Graphics (QUAD) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.26 per share a year ago. These ...
Quad/Graphics (NYSE:QUAD) will release its quarterly earnings report on Tuesday, 2025-10-28. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Quad/Graphics to ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The plant closings are part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results